Join BMO and industry leaders in New York on March 25 for the BMO 2025 Obesity Summit to discuss the growing $150 billion obesity therapies market. The Summit features an exciting line-up of leaders ...

While President Trump is currently shaking international norms, there is one area where his challenge to global institutions is profoundly good: ending America’s acquiescence to the Organisation ...

People taking the drugs had a lower risk of organ failure and death However, the drugs were associated with an increased risk of diabetic retinopathy THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 ...

THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...

Then came the GLP-1 revolution in form of weight-loss drugs such as Ozempic and Wegovy, game-changers in the market. They have blown the doors off products such as SlimFast. A top-to-bottom ...

“Yes, I am on a GLP-1, or a weight loss medication." "Now, if you have been following me for a long time, you’ll know that I’ve gained and lost weight several times very publicly," they ...

I expect price sensitive consumers to flood the market for compounded GLP-1 drugs before the 60-day FDA grace period for semaglutide compounders. HIMS projects $725M in GLP-1 weight loss revenue ...

Hims has sold one-month doses of GLP-1 semaglutides starting at $165 per month. The list cost of Wegovy is $1,349, and one dose is generally taken every four weeks. Andrew Dudum, co-founder of Hims ...

With the rising global obesity epidemic and the increasing demand for effective weight-loss treatments, the biopharma industry faces mounting pressure to revolutionize GLP-1 manufacturing to meet ...

ORLANDO, FLA. — What the full impact of GLP-1 medications will be on food and beverage consumption patterns is impossible to know. Use of the medications today is limited and there is much to ...